BeiGene names Aaron Rosenberg CFO effective July 22; Julia Wang resigns

BeOne Medicines Ltd.

Aaron Rosenberg appointed CFO effective July 22; Julia Wang resigns effective July 19, stays as Senior Advisor through Aug 31.
Rosenberg receives $620k base salary, 60% target bonus, $5M equity award (mix of RSUs, options, PSUs).
Wang receives $930k severance (18 months base) plus $559.5k for bonus/benefits; 18-month accelerated vesting of prior equity grants.
Wang's resignation is not the result of any dispute or disagreement with BeiGene's board or management.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Aaron Rosenberg

Chief Financial Officer

ONC · BeOne Medicines Ltd.

Effective: 2024-07-22
Filed: July 18, 2024, 7:59 PM ET

On July 18, 2024, BeiGene, Ltd. (the “Company”) announced the appointment of Aaron Rosenberg as the Chief Financial Officer (“CFO”) and the principal financial officer of the Company, effective as of July 22, 2024 (the “Effective Date”).

Departed

Julia Wang

Chief Financial Officer

ONC · BeOne Medicines Ltd.

Effective: 2024-07-19
Successor: Aaron Rosenberg
Filed: July 18, 2024, 7:59 PM ET

On July 17, 2024, Julia Wang, the Company’s current CFO, resigned as CFO effective July 19, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Aaron Rosenberg was appointed as Chief Financial Officer at BeOne Medicines Ltd..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 18, 2024, BeiGene, Ltd. (the “Company”) announced the appointment of Aaron Rosenberg as the Chief Financial Officer (“CFO”) and the principal financial officer of the Company, effective as of July 22, 2024 (the “Effective Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Julia Wang resigned as Chief Financial Officer at BeOne Medicines Ltd..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On July 17, 2024, Julia Wang, the Company’s current CFO, resigned as CFO effective July 19, 2024.

View on SEC.gov

BeOne Medicines Ltd. filing history →

Source: SEC EDGAR

accession 0001651308-24-000086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.